TGFBR1 and colorectal cancer: We crossed Tgfbr1 haploinsufficient mice with ApcMin/+ mice, one of the most commonly used models of colorectal cancer, and found that constitutively decreased Tgfbr1 signaling is a potent modifier of colorectal cancer risk[12].